Welcome, Flavocure

We warmly welcome Flavocure Biotech to Harbor Launch. Led by Ngeh Toyang, PhD –┬áCEO, Flavocure is a Maryland corporation founded in 2015 to discover, develop, and commercialize novel therapeutics based on naturally occurring ingredients for the treatment and management of various diseases. The Founder & Executive Chairman of Flavocure is Dr. Henry L. C. Lowe, PhD, and the Chief Financial Officer is Tony Deasey. Their first product is a small molecule drug for the treatment of Acute Myeloid Leukemia (AML), which is a rare and aggressive cancer of the blood and bone marrow that affects approximately 350,000 people worldwide.

 

Leave a Reply

Your email address will not be published. Required fields are marked *